MirNAS and their putative roles in the development and progression of Parkinson's disease

Garry Wong, Richard Nass

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Small regulatory RNAs, such as miRNAs, are increasingly being recognized not only as regulators of developmental processes but contributors to pathological states. The number of miRNAs determined experimentally to be involved in Parkinson's disease (PD) development and progression is small and includes regulators of pathologic proteins, neurotrophic factors, and xenobiotic metabolizing enzymes. PD gene-association studies have also indicated miRNAs in the pathology. In this review, we present known miRNAs and their validated targets that contribute to PD development and progression. We also incorporate data mining methods to link additional miRNAs with non-experimentally validated targets and propose additional roles of miRNAs in neurodegenerative processes. Furthermore, we present the potential contribution of next-generation-sequencing approaches to elucidate mechanisms and etiology of PD through discovery of novel miRNAs and other non-coding RNA classes.

Original languageEnglish
Article numberArticle 315
JournalFrontiers in Genetics
Volume3
Issue numberJAN
DOIs
StatePublished - 2013

Fingerprint

MicroRNAs
Parkinson Disease
Disease Progression
Untranslated RNA
Data Mining
Nerve Growth Factors
Xenobiotics
RNA
Pathology
Enzymes
Genes
Proteins

Keywords

  • Alpha-synuclein
  • Dopamine
  • Mir-7
  • Neurodegeneration

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Cite this

MirNAS and their putative roles in the development and progression of Parkinson's disease. / Wong, Garry; Nass, Richard.

In: Frontiers in Genetics, Vol. 3, No. JAN, Article 315, 2013.

Research output: Contribution to journalArticle

@article{f668f9d881304373a093059208d0363d,
title = "MirNAS and their putative roles in the development and progression of Parkinson's disease",
abstract = "Small regulatory RNAs, such as miRNAs, are increasingly being recognized not only as regulators of developmental processes but contributors to pathological states. The number of miRNAs determined experimentally to be involved in Parkinson's disease (PD) development and progression is small and includes regulators of pathologic proteins, neurotrophic factors, and xenobiotic metabolizing enzymes. PD gene-association studies have also indicated miRNAs in the pathology. In this review, we present known miRNAs and their validated targets that contribute to PD development and progression. We also incorporate data mining methods to link additional miRNAs with non-experimentally validated targets and propose additional roles of miRNAs in neurodegenerative processes. Furthermore, we present the potential contribution of next-generation-sequencing approaches to elucidate mechanisms and etiology of PD through discovery of novel miRNAs and other non-coding RNA classes.",
keywords = "Alpha-synuclein, Dopamine, Mir-7, Neurodegeneration",
author = "Garry Wong and Richard Nass",
year = "2013",
doi = "10.3389/fgene.2012.00315",
language = "English",
volume = "3",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "JAN",

}

TY - JOUR

T1 - MirNAS and their putative roles in the development and progression of Parkinson's disease

AU - Wong, Garry

AU - Nass, Richard

PY - 2013

Y1 - 2013

N2 - Small regulatory RNAs, such as miRNAs, are increasingly being recognized not only as regulators of developmental processes but contributors to pathological states. The number of miRNAs determined experimentally to be involved in Parkinson's disease (PD) development and progression is small and includes regulators of pathologic proteins, neurotrophic factors, and xenobiotic metabolizing enzymes. PD gene-association studies have also indicated miRNAs in the pathology. In this review, we present known miRNAs and their validated targets that contribute to PD development and progression. We also incorporate data mining methods to link additional miRNAs with non-experimentally validated targets and propose additional roles of miRNAs in neurodegenerative processes. Furthermore, we present the potential contribution of next-generation-sequencing approaches to elucidate mechanisms and etiology of PD through discovery of novel miRNAs and other non-coding RNA classes.

AB - Small regulatory RNAs, such as miRNAs, are increasingly being recognized not only as regulators of developmental processes but contributors to pathological states. The number of miRNAs determined experimentally to be involved in Parkinson's disease (PD) development and progression is small and includes regulators of pathologic proteins, neurotrophic factors, and xenobiotic metabolizing enzymes. PD gene-association studies have also indicated miRNAs in the pathology. In this review, we present known miRNAs and their validated targets that contribute to PD development and progression. We also incorporate data mining methods to link additional miRNAs with non-experimentally validated targets and propose additional roles of miRNAs in neurodegenerative processes. Furthermore, we present the potential contribution of next-generation-sequencing approaches to elucidate mechanisms and etiology of PD through discovery of novel miRNAs and other non-coding RNA classes.

KW - Alpha-synuclein

KW - Dopamine

KW - Mir-7

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=84876183915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876183915&partnerID=8YFLogxK

U2 - 10.3389/fgene.2012.00315

DO - 10.3389/fgene.2012.00315

M3 - Article

VL - 3

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - JAN

M1 - Article 315

ER -